Christina Jenkins, MD
Dr. Jenkins (“CJ”) is a Venture Partner at PVP, where she co-leads the firm’s seed-stage investment strategy in the life sciences vertical. CJ is focused on hardware-enabled platform companies that are transforming the way we diagnose, monitor, and treat health conditions. She finds joy in working alongside those who are relentless in making health, better. She applies her unique perspective of providers, payers and consumers to help optimize growth and health outcomes.
Previously, Dr. Jenkins was the founding CEO of OneCity Health Services, a subsidiary of NYC Health + Hospitals (H+H), building a team from 2 to 130. She led a successful $1.2B effort to build technology-enabled care models and accelerate value-based payment (financial risk) readiness for 1M lives.
She is a Board Director for Independence Health Group (parent of Independence Blue Cross and AmeriHealth Caritas), a Board Observer for Madorra, and an advisory board member of multiple value-generating healthcare companies. She also leads investments for Portfolia’s FemTech and Active Aging and Longevity funds, focusing on evidence-backed digital health and device companies targeting the health of women.
CJ is a member of the Kauffman Fellows, a global leadership program in venture capital, completing her fellowship at New Enterprise Associates (NEA). She was a Clinical Instructor in Internal Medicine at Mount Sinai Medical Center in NYC, and began her career as a financial analyst with General Electric Healthcare.
Sectors: Healthcare, Life Sciences
Stages: Seed, Venture